The global Valsartan Drug market was valued at US$ 589 million in 2023 and is anticipated to reach US$ 866.2 million by 2030, witnessing a CAGR of 6.4% during the forecast period 2024-2030.

Valsartan Drug Market

Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Valsartan Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valsartan Drug.

Report Scope

The Valsartan Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valsartan Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Valsartan Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Valsartan Drug Market Report

Report Metric	Details
Report Name	Valsartan Drug Market
Accounted market size in 2023	US$ 589 million
Forecasted market size in 2030	US$ 866.2 million
CAGR	6.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	40 mg Tablets 80 mg Tablets 160 mg Tablets 320 mg Tablets
Segment by Application	Hypertension Heart Failure Heart Attack
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals, HETERO, Torrent Pharmaceuticals, Huaren Pharmaceutical, Jubilant Pharma, Amneal Pharmaceuticals, Zhejiang Huahai Pharmaceutical, Square Pharmaceuticals, Unichem Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valsartan Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valsartan Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Valsartan Drug Market growing?

Ans: The Valsartan Drug Market witnessing a CAGR of 6.4% during the forecast period 2024-2030.

What is the Valsartan Drug Market size in 2030?

Ans: The Valsartan Drug Market size in 2030 will be US$ 866.2 million.

Who are the main players in the Valsartan Drug Market report?

Ans: The main players in the Valsartan Drug Market are Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals, HETERO, Torrent Pharmaceuticals, Huaren Pharmaceutical, Jubilant Pharma, Amneal Pharmaceuticals, Zhejiang Huahai Pharmaceutical, Square Pharmaceuticals, Unichem Laboratories

What are the Application segmentation covered in the Valsartan Drug Market report?

Ans: The Applications covered in the Valsartan Drug Market report are Hypertension, Heart Failure, Heart Attack

What are the Type segmentation covered in the Valsartan Drug Market report?

Ans: The Types covered in the Valsartan Drug Market report are 40 mg Tablets, 80 mg Tablets, 160 mg Tablets, 320 mg Tablets

1 Valsartan Drug Market Overview

1.1 Product Overview and Scope of Valsartan Drug

1.2 Valsartan Drug Segment by Type

1.2.1 Global Valsartan Drug Market Value Comparison by Type (2024-2030)

1.2.2 40 mg Tablets

1.2.3 80 mg Tablets

1.2.4 160 mg Tablets

1.2.5 320 mg Tablets

1.3 Valsartan Drug Segment by Application

1.3.1 Global Valsartan Drug Market Value by Application: (2024-2030)

1.3.2 Hypertension

1.3.3 Heart Failure

1.3.4 Heart Attack

1.4 Global Valsartan Drug Market Size Estimates and Forecasts

1.4.1 Global Valsartan Drug Revenue 2019-2030

1.4.2 Global Valsartan Drug Sales 2019-2030

1.4.3 Global Valsartan Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Valsartan Drug Market Competition by Manufacturers

2.1 Global Valsartan Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Valsartan Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Valsartan Drug Average Price by Manufacturers (2019-2024)

2.4 Global Valsartan Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Valsartan Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Valsartan Drug, Product Type & Application

2.7 Valsartan Drug Market Competitive Situation and Trends

2.7.1 Valsartan Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Valsartan Drug Players Market Share by Revenue

2.7.3 Global Valsartan Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Valsartan Drug Retrospective Market Scenario by Region

3.1 Global Valsartan Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Valsartan Drug Global Valsartan Drug Sales by Region: 2019-2030

3.2.1 Global Valsartan Drug Sales by Region: 2019-2024

3.2.2 Global Valsartan Drug Sales by Region: 2025-2030

3.3 Global Valsartan Drug Global Valsartan Drug Revenue by Region: 2019-2030

3.3.1 Global Valsartan Drug Revenue by Region: 2019-2024

3.3.2 Global Valsartan Drug Revenue by Region: 2025-2030

3.4 North America Valsartan Drug Market Facts & Figures by Country

3.4.1 North America Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Valsartan Drug Sales by Country (2019-2030)

3.4.3 North America Valsartan Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Valsartan Drug Market Facts & Figures by Country

3.5.1 Europe Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Valsartan Drug Sales by Country (2019-2030)

3.5.3 Europe Valsartan Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Valsartan Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Valsartan Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Valsartan Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Valsartan Drug Market Facts & Figures by Country

3.7.1 Latin America Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Valsartan Drug Sales by Country (2019-2030)

3.7.3 Latin America Valsartan Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Valsartan Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Valsartan Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Valsartan Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Valsartan Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Valsartan Drug Sales by Type (2019-2030)

4.1.1 Global Valsartan Drug Sales by Type (2019-2024)

4.1.2 Global Valsartan Drug Sales by Type (2025-2030)

4.1.3 Global Valsartan Drug Sales Market Share by Type (2019-2030)

4.2 Global Valsartan Drug Revenue by Type (2019-2030)

4.2.1 Global Valsartan Drug Revenue by Type (2019-2024)

4.2.2 Global Valsartan Drug Revenue by Type (2025-2030)

4.2.3 Global Valsartan Drug Revenue Market Share by Type (2019-2030)

4.3 Global Valsartan Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Valsartan Drug Sales by Application (2019-2030)

5.1.1 Global Valsartan Drug Sales by Application (2019-2024)

5.1.2 Global Valsartan Drug Sales by Application (2025-2030)

5.1.3 Global Valsartan Drug Sales Market Share by Application (2019-2030)

5.2 Global Valsartan Drug Revenue by Application (2019-2030)

5.2.1 Global Valsartan Drug Revenue by Application (2019-2024)

5.2.2 Global Valsartan Drug Revenue by Application (2025-2030)

5.2.3 Global Valsartan Drug Revenue Market Share by Application (2019-2030)

5.3 Global Valsartan Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Novartis

6.1.1 Novartis Corporation Information

6.1.2 Novartis Description and Business Overview

6.1.3 Novartis Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Novartis Valsartan Drug Product Portfolio

6.1.5 Novartis Recent Developments/Updates

6.2 Sun Pharmaceutical

6.2.1 Sun Pharmaceutical Corporation Information

6.2.2 Sun Pharmaceutical Description and Business Overview

6.2.3 Sun Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Sun Pharmaceutical Valsartan Drug Product Portfolio

6.2.5 Sun Pharmaceutical Recent Developments/Updates

6.3 Teva

6.3.1 Teva Corporation Information

6.3.2 Teva Description and Business Overview

6.3.3 Teva Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Teva Valsartan Drug Product Portfolio

6.3.5 Teva Recent Developments/Updates

6.4 Mylan

6.4.1 Mylan Corporation Information

6.4.2 Mylan Description and Business Overview

6.4.3 Mylan Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Mylan Valsartan Drug Product Portfolio

6.4.5 Mylan Recent Developments/Updates

6.5 Alembic Pharmaceuticals

6.5.1 Alembic Pharmaceuticals Corporation Information

6.5.2 Alembic Pharmaceuticals Description and Business Overview

6.5.3 Alembic Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Alembic Pharmaceuticals Valsartan Drug Product Portfolio

6.5.5 Alembic Pharmaceuticals Recent Developments/Updates

6.6 Lupin

6.6.1 Lupin Corporation Information

6.6.2 Lupin Description and Business Overview

6.6.3 Lupin Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Lupin Valsartan Drug Product Portfolio

6.6.5 Lupin Recent Developments/Updates

6.7 Aurobindo Pharma

6.6.1 Aurobindo Pharma Corporation Information

6.6.2 Aurobindo Pharma Description and Business Overview

6.6.3 Aurobindo Pharma Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Aurobindo Pharma Valsartan Drug Product Portfolio

6.7.5 Aurobindo Pharma Recent Developments/Updates

6.8 Macleods Pharmaceuticals

6.8.1 Macleods Pharmaceuticals Corporation Information

6.8.2 Macleods Pharmaceuticals Description and Business Overview

6.8.3 Macleods Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Macleods Pharmaceuticals Valsartan Drug Product Portfolio

6.8.5 Macleods Pharmaceuticals Recent Developments/Updates

6.9 HETERO

6.9.1 HETERO Corporation Information

6.9.2 HETERO Description and Business Overview

6.9.3 HETERO Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.9.4 HETERO Valsartan Drug Product Portfolio

6.9.5 HETERO Recent Developments/Updates

6.10 Torrent Pharmaceuticals

6.10.1 Torrent Pharmaceuticals Corporation Information

6.10.2 Torrent Pharmaceuticals Description and Business Overview

6.10.3 Torrent Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Torrent Pharmaceuticals Valsartan Drug Product Portfolio

6.10.5 Torrent Pharmaceuticals Recent Developments/Updates

6.11 Huaren Pharmaceutical

6.11.1 Huaren Pharmaceutical Corporation Information

6.11.2 Huaren Pharmaceutical Valsartan Drug Description and Business Overview

6.11.3 Huaren Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Huaren Pharmaceutical Valsartan Drug Product Portfolio

6.11.5 Huaren Pharmaceutical Recent Developments/Updates

6.12 Jubilant Pharma

6.12.1 Jubilant Pharma Corporation Information

6.12.2 Jubilant Pharma Valsartan Drug Description and Business Overview

6.12.3 Jubilant Pharma Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Jubilant Pharma Valsartan Drug Product Portfolio

6.12.5 Jubilant Pharma Recent Developments/Updates

6.13 Amneal Pharmaceuticals

6.13.1 Amneal Pharmaceuticals Corporation Information

6.13.2 Amneal Pharmaceuticals Valsartan Drug Description and Business Overview

6.13.3 Amneal Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Amneal Pharmaceuticals Valsartan Drug Product Portfolio

6.13.5 Amneal Pharmaceuticals Recent Developments/Updates

6.14 Zhejiang Huahai Pharmaceutical

6.14.1 Zhejiang Huahai Pharmaceutical Corporation Information

6.14.2 Zhejiang Huahai Pharmaceutical Valsartan Drug Description and Business Overview

6.14.3 Zhejiang Huahai Pharmaceutical Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Zhejiang Huahai Pharmaceutical Valsartan Drug Product Portfolio

6.14.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates

6.15 Square Pharmaceuticals

6.15.1 Square Pharmaceuticals Corporation Information

6.15.2 Square Pharmaceuticals Valsartan Drug Description and Business Overview

6.15.3 Square Pharmaceuticals Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Square Pharmaceuticals Valsartan Drug Product Portfolio

6.15.5 Square Pharmaceuticals Recent Developments/Updates

6.16 Unichem Laboratories

6.16.1 Unichem Laboratories Corporation Information

6.16.2 Unichem Laboratories Valsartan Drug Description and Business Overview

6.16.3 Unichem Laboratories Valsartan Drug Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Unichem Laboratories Valsartan Drug Product Portfolio

6.16.5 Unichem Laboratories Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Valsartan Drug Industry Chain Analysis

7.2 Valsartan Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Valsartan Drug Production Mode & Process

7.4 Valsartan Drug Sales and Marketing

7.4.1 Valsartan Drug Sales Channels

7.4.2 Valsartan Drug Distributors

7.5 Valsartan Drug Customers

8 Valsartan Drug Market Dynamics

8.1 Valsartan Drug Industry Trends

8.2 Valsartan Drug Market Drivers

8.3 Valsartan Drug Market Challenges

8.4 Valsartan Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Alembic Pharmaceuticals

Lupin Ltd

Aurobindo Pharma

Macleods Pharmaceuticals

Hetero

Torrent Pharmaceuticals

Huaren Pharmaceutical

Jubilant Pharma

Amneal Pharmaceuticals

Zhejiang Huahai Pharmaceutical

Square Pharmaceuticals

Unichem Laboratories

List of Tables

Table 1. Global Valsartan Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Valsartan Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Valsartan Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Valsartan Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Valsartan Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Valsartan Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Valsartan Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Valsartan Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Valsartan Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Valsartan Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Valsartan Drug, Product Type & Application

Table 12. Global Key Manufacturers of Valsartan Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Valsartan Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Valsartan Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Valsartan Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global Valsartan Drug Sales Market Share by Region (2019-2024)

Table 19. Global Valsartan Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global Valsartan Drug Sales Market Share by Region (2025-2030)

Table 21. Global Valsartan Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Valsartan Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Valsartan Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Valsartan Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Valsartan Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Valsartan Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America Valsartan Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America Valsartan Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Valsartan Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Valsartan Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Valsartan Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe Valsartan Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe Valsartan Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Valsartan Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Valsartan Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Valsartan Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Valsartan Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Valsartan Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Valsartan Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Valsartan Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Valsartan Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Valsartan Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Valsartan Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Valsartan Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Valsartan Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Valsartan Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Valsartan Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Valsartan Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Valsartan Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Valsartan Drug Sales (K Units) by Type (2019-2024)

Table 51. Global Valsartan Drug Sales (K Units) by Type (2025-2030)

Table 52. Global Valsartan Drug Sales Market Share by Type (2019-2024)

Table 53. Global Valsartan Drug Sales Market Share by Type (2025-2030)

Table 54. Global Valsartan Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Valsartan Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Valsartan Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Valsartan Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Valsartan Drug Price (USD/Unit) by Type (2019-2024)

Table 59. Global Valsartan Drug Price (USD/Unit) by Type (2025-2030)

Table 60. Global Valsartan Drug Sales (K Units) by Application (2019-2024)

Table 61. Global Valsartan Drug Sales (K Units) by Application (2025-2030)

Table 62. Global Valsartan Drug Sales Market Share by Application (2019-2024)

Table 63. Global Valsartan Drug Sales Market Share by Application (2025-2030)

Table 64. Global Valsartan Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Valsartan Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Valsartan Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Valsartan Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Valsartan Drug Price (USD/Unit) by Application (2019-2024)

Table 69. Global Valsartan Drug Price (USD/Unit) by Application (2025-2030)

Table 70. Novartis Corporation Information

Table 71. Novartis Description and Business Overview

Table 72. Novartis Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Novartis Valsartan Drug Product

Table 74. Novartis Recent Developments/Updates

Table 75. Sun Pharmaceutical Corporation Information

Table 76. Sun Pharmaceutical Description and Business Overview

Table 77. Sun Pharmaceutical Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Sun Pharmaceutical Valsartan Drug Product

Table 79. Sun Pharmaceutical Recent Developments/Updates

Table 80. Teva Corporation Information

Table 81. Teva Description and Business Overview

Table 82. Teva Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Teva Valsartan Drug Product

Table 84. Teva Recent Developments/Updates

Table 85. Mylan Corporation Information

Table 86. Mylan Description and Business Overview

Table 87. Mylan Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Mylan Valsartan Drug Product

Table 89. Mylan Recent Developments/Updates

Table 90. Alembic Pharmaceuticals Corporation Information

Table 91. Alembic Pharmaceuticals Description and Business Overview

Table 92. Alembic Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Alembic Pharmaceuticals Valsartan Drug Product

Table 94. Alembic Pharmaceuticals Recent Developments/Updates

Table 95. Lupin Corporation Information

Table 96. Lupin Description and Business Overview

Table 97. Lupin Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Lupin Valsartan Drug Product

Table 99. Lupin Recent Developments/Updates

Table 100. Aurobindo Pharma Corporation Information

Table 101. Aurobindo Pharma Description and Business Overview

Table 102. Aurobindo Pharma Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Aurobindo Pharma Valsartan Drug Product

Table 104. Aurobindo Pharma Recent Developments/Updates

Table 105. Macleods Pharmaceuticals Corporation Information

Table 106. Macleods Pharmaceuticals Description and Business Overview

Table 107. Macleods Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Macleods Pharmaceuticals Valsartan Drug Product

Table 109. Macleods Pharmaceuticals Recent Developments/Updates

Table 110. HETERO Corporation Information

Table 111. HETERO Description and Business Overview

Table 112. HETERO Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. HETERO Valsartan Drug Product

Table 114. HETERO Recent Developments/Updates

Table 115. Torrent Pharmaceuticals Corporation Information

Table 116. Torrent Pharmaceuticals Description and Business Overview

Table 117. Torrent Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Torrent Pharmaceuticals Valsartan Drug Product

Table 119. Torrent Pharmaceuticals Recent Developments/Updates

Table 120. Huaren Pharmaceutical Corporation Information

Table 121. Huaren Pharmaceutical Description and Business Overview

Table 122. Huaren Pharmaceutical Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Huaren Pharmaceutical Valsartan Drug Product

Table 124. Huaren Pharmaceutical Recent Developments/Updates

Table 125. Jubilant Pharma Corporation Information

Table 126. Jubilant Pharma Description and Business Overview

Table 127. Jubilant Pharma Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Jubilant Pharma Valsartan Drug Product

Table 129. Jubilant Pharma Recent Developments/Updates

Table 130. Amneal Pharmaceuticals Corporation Information

Table 131. Amneal Pharmaceuticals Description and Business Overview

Table 132. Amneal Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Amneal Pharmaceuticals Valsartan Drug Product

Table 134. Amneal Pharmaceuticals Recent Developments/Updates

Table 135. Zhejiang Huahai Pharmaceutical Corporation Information

Table 136. Zhejiang Huahai Pharmaceutical Description and Business Overview

Table 137. Zhejiang Huahai Pharmaceutical Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Zhejiang Huahai Pharmaceutical Valsartan Drug Product

Table 139. Zhejiang Huahai Pharmaceutical Recent Developments/Updates

Table 140. Square Pharmaceuticals Corporation Information

Table 141. Square Pharmaceuticals Description and Business Overview

Table 142. Square Pharmaceuticals Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 143. Square Pharmaceuticals Valsartan Drug Product

Table 144. Square Pharmaceuticals Recent Developments/Updates

Table 145. Unichem Laboratories Corporation Information

Table 146. Unichem Laboratories Description and Business Overview

Table 147. Unichem Laboratories Valsartan Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 148. Unichem Laboratories Valsartan Drug Product

Table 149. Unichem Laboratories Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Valsartan Drug Distributors List

Table 153. Valsartan Drug Customers List

Table 154. Valsartan Drug Market Trends

Table 155. Valsartan Drug Market Drivers

Table 156. Valsartan Drug Market Challenges

Table 157. Valsartan Drug Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Valsartan Drug

Figure 2. Global Valsartan Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Valsartan Drug Market Share by Type in 2023 & 2030

Figure 4. 40 mg Tablets Product Picture

Figure 5. 80 mg Tablets Product Picture

Figure 6. 160 mg Tablets Product Picture

Figure 7. 320 mg Tablets Product Picture

Figure 8. Global Valsartan Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Valsartan Drug Market Share by Application in 2023 & 2030

Figure 10. Hypertension

Figure 11. Heart Failure

Figure 12. Heart Attack

Figure 13. Global Valsartan Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Valsartan Drug Market Size (2019-2030) & (US$ Million)

Figure 15. Global Valsartan Drug Sales (2019-2030) & (K Units)

Figure 16. Global Valsartan Drug Average Price (USD/Unit) & (2019-2030)

Figure 17. Valsartan Drug Report Years Considered

Figure 18. Valsartan Drug Sales Share by Manufacturers in 2023

Figure 19. Global Valsartan Drug Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Valsartan Drug Players: Market Share by Revenue in 2023

Figure 21. Valsartan Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Valsartan Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Valsartan Drug Sales Market Share by Country (2019-2030)

Figure 24. North America Valsartan Drug Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Valsartan Drug Sales Market Share by Country (2019-2030)

Figure 28. Europe Valsartan Drug Revenue Market Share by Country (2019-2030)

Figure 29. Germany Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Valsartan Drug Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Valsartan Drug Revenue Market Share by Region (2019-2030)

Figure 36. China Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Valsartan Drug Sales Market Share by Country (2019-2030)

Figure 47. Latin America Valsartan Drug Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Valsartan Drug Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Valsartan Drug Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. UAE Valsartan Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Valsartan Drug by Type (2019-2030)

Figure 57. Global Revenue Market Share of Valsartan Drug by Type (2019-2030)

Figure 58. Global Valsartan Drug Price (USD/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Valsartan Drug by Application (2019-2030)

Figure 60. Global Revenue Market Share of Valsartan Drug by Application (2019-2030)

Figure 61. Global Valsartan Drug Price (USD/Unit) by Application (2019-2030)

Figure 62. Valsartan Drug Value Chain

Figure 63. Valsartan Drug Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions